Paper32508331
GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop.
Barker RA and 30 others. J Parkinsons Dis, 2020. Cited by 120 papers, by iCite.
Cite this record
ConductScience Library. GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop. Papers, record 32508331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32508331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glial Cell Line-Derived Neurotrophic Factor | Major topic |
| Neuroprotective Agents | Major topic |
| Parkinson Disease | Major topic |
| Animals | |
| Dopaminergic Neurons | |
| Genetic Therapy | |
| Humans |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27717005 | Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's. | Ann Neurol | 2016 | https://conductscience.org/library/papers/27717005 | PubMed |
| 2 | 26924352 | AAV viral vector delivery to the brain by shape-conforming MR-guided infusions. | J Control Release | 2016 | https://conductscience.org/library/papers/26924352 | PubMed |
| 3 | 23884810 | Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. | Brain | 2013 | https://conductscience.org/library/papers/23884810 | PubMed |
| 4 | 24566411 | 18F-DOPA, a clinically available PET tracer to study brain inflammation? | Clin Nucl Med | 2014 | https://conductscience.org/library/papers/24566411 | PubMed |
| 5 | 28522034 | Alpha-Synuclein mRNA Is Not Increased in Sporadic PD and Alpha-Synuclein Accumulation Does Not Block GDNF Signaling in Parkinson's Disease and Disease Models. | Mol Ther | 2017 | https://conductscience.org/library/papers/28522034 | PubMed |
| 6 | 30808022 | Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease. | Brain | 2019 | https://conductscience.org/library/papers/30808022 | PubMed |
| 7 | 22019719 | Glial-derived neurotrophic factor gene transfer for Parkinson's disease: anterograde distribution of AAV2 vectors in the primate brain. | Neurobiol Dis | 2012 | https://conductscience.org/library/papers/22019719 | PubMed |
| 8 | 30802998 | Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease. | Ann Neurol | 2019 | https://conductscience.org/library/papers/30802998 | PubMed |
| 9 | 30103283 | Trophic factors for Parkinson's disease: Where are we and where do we go from here? | Eur J Neurosci | 2019 | https://conductscience.org/library/papers/30103283 | PubMed |
| 10 | 19615368 | Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons. | Exp Neurol | 2009 | https://conductscience.org/library/papers/19615368 | PubMed |
| 11 | 12669033 | Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. | Nat Med | 2003 | https://conductscience.org/library/papers/12669033 | PubMed |
| 12 | 16429411 | Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. | Ann Neurol | 2006 | https://conductscience.org/library/papers/16429411 | PubMed |
| 13 | 30139598 | The effects of image reconstruction algorithms on topographic characteristics, diagnostic performance and clinical correlation of metabolic brain networks in Parkinson's disease. | Phys Med | 2018 | https://conductscience.org/library/papers/30139598 | PubMed |
| 14 | 29151169 | Parkinson's disease: experimental models and reality. | Acta Neuropathol | 2018 | https://conductscience.org/library/papers/29151169 | PubMed |
| 15 | 26061140 | Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. | Ann Neurol | 2015 | https://conductscience.org/library/papers/26061140 | PubMed |
| 16 | 23220632 | α-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons. | Sci Transl Med | 2012 | https://conductscience.org/library/papers/23220632 | PubMed |
| 17 | 30947516 | CDNF Protein Therapy in Parkinson's Disease. | Cell Transplant | 2019 | https://conductscience.org/library/papers/30947516 | PubMed |
| 18 | 22418061 | Axonal transport of adeno-associated viral vectors is serotype-dependent. | Gene Ther | 2013 | https://conductscience.org/library/papers/22418061 | PubMed |
| 19 | 12525720 | Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. | Neurology | 2003 | https://conductscience.org/library/papers/12525720 | PubMed |
| 20 | 31145831 | Trial of magnetic resonance-guided putaminal gene therapy for advanced Parkinson's disease. | Mov Disord | 2019 | https://conductscience.org/library/papers/31145831 | PubMed |
Cited by90
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985051 | Intracerebroventricular delivery of an ODN peptide analog protects dopaminergic neurons and modulates miRNA expression in a mouse model of Parkinson's disease. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42985051 | PubMed |
| 42750142 | Disrupted TFEB/GDNF-cAMP/ATP Coupling Underlies Astrocytic Dysfunction and Depression in LRRK2 G2019S Parkinson's Mice. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42750142 | PubMed |
| 42742463 | Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape. | J Parkinsons Dis | 2026 | https://conductscience.org/library/papers/42742463 | PubMed |
| 42737359 | Preventive Attenuation of MPTP-Induced Parkinson's Disease-like Abnormalities by Lactiplantibacillus plantarum SHOU LAC-1 in Mice. | Foods | 2026 | https://conductscience.org/library/papers/42737359 | PubMed |
| 42400752 | Exerkine-Mediated Regulation of the NLRP3 Inflammasome in Neuroprotection: Mechanistic Insights and the Role of Exercise. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42400752 | PubMed |
| 42390947 | NLX-112, a Selective 5-HT1A Receptor Agonist, Upregulates GDNF and is Neuroprotective Against MPTP-Induced Nigrostriatal Degeneration in a Mouse Model of Parkinson's Disease. | ACS Chem Neurosci | 2026 | https://conductscience.org/library/papers/42390947 | PubMed |
| 42277926 | PAK1 expression protects cellular and behavioral defects in animal models of Parkinson' s disease. | Mol Brain | 2026 | https://conductscience.org/library/papers/42277926 | PubMed |
| 42146749 | Advancing Parkinson's Prevention: Brain-Specific Lipopolyplex Delivery of the GDNF as a Neuroprotective Gene Therapy. | ACS Mater Au | 2026 | https://conductscience.org/library/papers/42146749 | PubMed |
| 42091584 | Clinical GDNF delivery methods for Parkinson's disease. | J Parkinsons Dis | 2026 | https://conductscience.org/library/papers/42091584 | PubMed |
| 41996076 | The expression of glial cell-derived neurotrophic factor in the hippocampal tissue of rats with vascular dementia and its correlation with molecular pathways involved in learning and memory impairment. | J Bioenerg Biomembr | 2026 | https://conductscience.org/library/papers/41996076 | PubMed |
| 41814010 | Redefining Parkinson's Disease management: the synergistic role of neurotrophic factors and mitochondria. | Cell Mol Life Sci | 2026 | https://conductscience.org/library/papers/41814010 | PubMed |
| 41750227 | Parkinson's Disease: Conventional Pharmacotherapy, Drug Delivery Innovations, and Emerging Therapeutic Targets. | Brain Sci | 2026 | https://conductscience.org/library/papers/41750227 | PubMed |
| 41743465 | Potential protein blood-based biomarkers for cognitive dysfunction in Parkinson's disease: a systematic review and network meta-analysis. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/41743465 | PubMed |
| 41703652 | Public involvement in the design of a complex neurosurgical clinical trial (the GDNF trial) and an associated support package: reflections and recommendations. | Trials | 2026 | https://conductscience.org/library/papers/41703652 | PubMed |
| 41697575 | BDNF and GDNF in Parkinson's Disease: Associations with Clinical Features, Disease Course, and Progression-A Systematic Review. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/41697575 | PubMed |
| 41562905 | Current State of the Neurotrophin-Based Pharmaceutics in the Treatment of Neurodegenerative Diseases and Neuroinflammation. | Med Sci (Basel) | 2025 | https://conductscience.org/library/papers/41562905 | PubMed |
| 41382340 | Phosphodiesterase Inhibition Increases Striatal GDNF and Protects Against Preclinical Parkinsonism. | J Neurochem | 2025 | https://conductscience.org/library/papers/41382340 | PubMed |
| 41193457 | Advancement in Gene Therapy for the Treatment of Parkinson's Disease: A Comprehensive Review. | Mini Rev Med Chem | 2026 | https://conductscience.org/library/papers/41193457 | PubMed |
| 40933823 | Exercise as a multitarget therapy: modulating myokines, neurotrophins, and inflammation in Parkinson's disease. | Front Aging Neurosci | 2025 | https://conductscience.org/library/papers/40933823 | PubMed |
| 40841722 | Integrating artificial intelligence and optogenetics for Parkinson's disease diagnosis and therapeutics in male mice. | Nat Commun | 2025 | https://conductscience.org/library/papers/40841722 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32508331
GET https://conductscience.org/api/papers/v1/32508331/authors?page=2